Clinical trial
Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as…
NCT00091247 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00091247 |
|---|---|
| Title | Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer |
| Official title | An Exploratory, Placebo-Controlled Trial of Prophylactic Tetracycline for Gefitinib-or Cetuximab-Induced Skin Rash (or Other Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Skin Rash) |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | tetracycline hydrochloride, placebo |
| Enrollment | 130 |
| Start date | Dec 1, 2004 |
| Primary completion | Aug 1, 2005 |
| Completion | Jul 1, 2009 |
| First posted | Sep 9, 2004 |
| Last update posted | Mar 16, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: